BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 12606359)

  • 1. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat.
    Yang H; Bhat GK; Wadley R; Wright KL; Chung BM; Whittaker JA; Dharmarajan AM; Sridaran R
    Biol Reprod; 2003 Jun; 68(6):2222-31. PubMed ID: 12606359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of steroidogenesis by luteal cells of early pregnancy in the rat in response to in vitro administration of a gonadotropin-releasing hormone agonist.
    Srivastava RK; Luu-The V; Marrone BL; Harris-Hooker S; Sridaran R
    J Steroid Biochem Mol Biol; 1994 May; 49(1):73-9. PubMed ID: 8003442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
    Sridaran R; Ghose M; Mahesh VB
    Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of type I GNRH receptor and in vivo and in vitro GNRH-I effects in corpora lutea of pseudopregnant rabbits.
    Zerani M; Parillo F; Brecchia G; Guelfi G; Dall'Aglio C; Lilli L; Maranesi M; Gobbetti A; Boiti C
    J Endocrinol; 2010 Dec; 207(3):289-300. PubMed ID: 20880984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist.
    Smith CJ; Richards JS; Yasin K; Sangster JN; Sridaran R
    Biol Reprod; 1991 Feb; 44(2):382-91. PubMed ID: 2009337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide stimulates progesterone and prostaglandin E2 secretion as well as angiogenic activity in the equine corpus luteum.
    Ferreira-Dias G; Costa AS; Mateus L; Korzekwa AJ; Galvão A; Redmer DA; Lukasik K; Szóstek AZ; Woclawek-Potocka I; Skarzynski DJ
    Domest Anim Endocrinol; 2011 Jan; 40(1):1-9. PubMed ID: 20961721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal and inducible nitric oxide synthase expression in the rat cerebellum following portacaval anastomosis.
    Suárez I; Bodega G; Rubio M; Felipo V; Fernández B
    Brain Res; 2005 Jun; 1047(2):205-13. PubMed ID: 15904901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of a nitric oxide synthase inhibitor counteracts prostaglandin F2-induced luteolysis in cattle.
    Skarzynski DJ; Jaroszewski JJ; Bah MM; Deptula KM; Barszczewska B; Gawronska B; Hansel W
    Biol Reprod; 2003 May; 68(5):1674-81. PubMed ID: 12606417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation.
    Sridaran R; Mahesh VB
    Biol Reprod; 1989 Feb; 40(2):276-82. PubMed ID: 2655722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of endothelial and inducible nitric oxide synthases and nitric oxide production in ovine placental and uterine tissues during late pregnancy.
    Zheng J; Li Y; Weiss AR; Bird IM; Magness RR
    Placenta; 2000; 21(5-6):516-24. PubMed ID: 10940202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy.
    Sridaran R; Philip GH; Li H; Culty M; Liu Z; Stocco DM; Papadopoulos V
    J Mol Endocrinol; 1999 Feb; 22(1):45-54. PubMed ID: 9924179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cytokines, p53 and nitric oxide synthase isoenzymes in corpora lutea of pseudopregnant rabbits during spontaneous luteolysis.
    Boiti C; Guelfi G; Zerani M; Zampini D; Brecchia G; Gobbetti A
    Reproduction; 2004 Feb; 127(2):229-38. PubMed ID: 15056789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of cytokines and progesterone in the regulation of the nitric oxide generating system in bovine luteal endothelial cells.
    Yoshioka S; Acosta TJ; Okuda K
    Mol Reprod Dev; 2012 Oct; 79(10):689-96. PubMed ID: 22847916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH action on luteal steroidogenesis during pregnancy.
    Sridaran R; Lee MA; Haynes L; Srivastava RK; Ghose M; Sridaran G; Smith CJ
    Steroids; 1999 Sep; 64(9):618-23. PubMed ID: 10503718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin F2alpha increases endothelial nitric oxide synthase in the periphery of the bovine corpus luteum: the possible regulation of blood flow at an early stage of luteolysis.
    Shirasuna K; Watanabe S; Asahi T; Wijayagunawardane MP; Sasahara K; Jiang C; Matsui M; Sasaki M; Shimizu T; Davis JS; Miyamoto A
    Reproduction; 2008 Apr; 135(4):527-39. PubMed ID: 18296510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production.
    Jaroszewski JJ; Bogacki M; Skarzynski DJ
    Reproduction; 2003 Mar; 125(3):389-95. PubMed ID: 12611602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of inducible and endothelial nitric oxide synthase in the rat ovary. Effects of gonadotropin stimulation in vivo.
    Van Voorhis BJ; Moore K; Strijbos PJ; Nelson S; Baylis SA; Grzybicki D; Weiner CP
    J Clin Invest; 1995 Dec; 96(6):2719-26. PubMed ID: 8675639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained gonadotropin-releasing hormone stimulation mobilizes the cAMP/PKA pathway to induce nitric oxide synthase type 1 expression in rat pituitary cells in vitro and in vivo at proestrus.
    Garrel G; Simon V; Thieulant ML; Cayla X; Garcia A; Counis R; Cohen-Tannoudji J
    Biol Reprod; 2010 Jun; 82(6):1170-9. PubMed ID: 20181617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.